Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Outset Medical Inc (NASDAQ: OM) closed at $0.70 down -11.82% from its previous closing price of $0.79. In other words, the price has decreased by -$11.82 from its previous closing price. On the day, 0.8 million shares were traded. OM stock price reached its highest trading level at $0.79 during the session, while it also had its lowest trading level at $0.6654.
Ratios:
For a deeper understanding of Outset Medical Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.04 and its Current Ratio is at 6.49. In the meantime, Its Debt-to-Equity ratio is 4.23 whereas as Long-Term Debt/Eq ratio is at 4.19.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, RBC Capital Mkts on August 08, 2024, Downgraded its rating to Sector Perform and sets its target price to $3 from $6 previously.
On June 21, 2024, RBC Capital Mkts Upgraded its rating to Outperform which previously was Sector Perform and also upped its target price recommendation from $5 to $6.
On April 08, 2024, BTIG Research started tracking the stock assigning a Buy rating and target price of $6.BTIG Research initiated its Buy rating on April 08, 2024, with a $6 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 15 ’24 when Trigg Leslie sold 5,645 shares for $0.80 per share. The transaction valued at 4,516 led to the insider holds 904,851 shares of the business.
Nash Marc sold 1,375 shares of OM for $1,100 on Nov 15 ’24. The SVP Operations and R&D now owns 238,022 shares after completing the transaction at $0.80 per share. On Nov 15 ’24, another insider, Brottem John L., who serves as the General Counsel of the company, sold 3,203 shares for $0.80 each. As a result, the insider received 2,562 and left with 227,092 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OM now has a Market Capitalization of 36690080 and an Enterprise Value of 68059032. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.29 while its Price-to-Book (P/B) ratio in mrq is 0.77. Its current Enterprise Value per Revenue stands at 0.593 whereas that against EBITDA is -0.553.
Stock Price History:
Over the past 52 weeks, OM has reached a high of $6.37, while it has fallen to a 52-week low of $0.44. The 50-Day Moving Average of the stock is 13.62%, while the 200-Day Moving Average is calculated to be -69.97%.
Shares Statistics:
For the past three months, OM has traded an average of 1.32M shares per day and 1466440 over the past ten days. A total of 50.32M shares are outstanding, with a floating share count of 48.21M. Insiders hold about 8.24% of the company’s shares, while institutions hold 51.53% stake in the company. Shares short for OM as of 1730332800 were 3348009 with a Short Ratio of 2.53, compared to 1727654400 on 3473477. Therefore, it implies a Short% of Shares Outstanding of 3348009 and a Short% of Float of 7.4499995.
